Our hypothesis is that CSF3R mutations arise in hematopoietic stem cells by selective pressure and are present at a low level until this cell clone becomes dominant through the continuous rhG-CSF treatment and acquisition of additional mutations in a leukemia-associated genes, such as RUNX1 (runt-related transcription factor 1) (20). Here, RUNX1 is linked to leukemia.